Skip to main content

and
  1. No Access

    Article

    Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia

    DNA methylation changes are a constant feature of acute myeloid leukemia. Hypomethylating drugs such as azacitidine are active in acute myeloid leukemia (AML) as monotherapy. Azacitidine monotherapy is not cur...

    C Müller-Tidow, P Tschanter, C Röllig, C Thiede, A Koschmieder, M Stelljes in Leukemia (2016)